CG
AMAG

Cutler Group’s AMAG Pharmaceuticals AMAG Stock Holding History

Cutler Group’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-500
Closed -$2K – 6356
2017
Q3 		$2K Buy
+500
New +$9.32K ﹤0.01% 5240
2017
Q1 		– Sell
-2,100
Closed -$7K – 7568
2016
Q4 		$7K Sell
2,100
-1,800
-46% -$53.8K ﹤0.01% 4663
2016
Q3 		$5K Buy
3,900
+500
+15% +$12.5K ﹤0.01% 5033
2016
Q2 		$6K Sell
3,400
-26,900
-89% -$617K ﹤0.01% 4824
2016
Q1 		$6K Buy
30,300
+18,500
+157% +$439K ﹤0.01% 4733
2015
Q4 		$29K Buy
+11,800
New +$381K ﹤0.01% 3033

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cutler Group's AMAG Position: Q1 2018 in Review

Cutler Group sold out of AMAG Pharmaceuticals (AMAG) in Q1 2018, closing a stake of 1,550 shares — an estimated $20K sold.

Cutler Group first reported a position in AMAG in Q4 2015 and held it in 9 quarters. The position peaked at $926K in Q2 2016. 170 funds tracked by Wall St. Rank hold AMAG as of Q1 2018.

  • Cutler Group reported no remaining AMAG Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • Cutler Group sold 1,550 AMAG Pharmaceuticals shares in Q1 2018, an estimated $20K.
  • Cutler Group first reported a position in AMAG Pharmaceuticals in Q4 2015 and held it in 9 quarters.
  • Cutler Group's AMAG Pharmaceuticals position peaked at $926K in Q2 2016.
  • 170 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2018.

Based on Cutler Group's 13F filing for Q1 2018, filed 11 May 2018.